DIFFERENTIAL EFFECT OF DITHIOTHREITOL AND DUP-753 ON ANGIOTENSIN-II RECEPTOR SUBTYPES IN BOVINE CEREBELLAR CORTEX

被引:4
|
作者
RENZETTI, AR
BARSACCHI, P
CATALIOTO, RM
CRISCUOLI, M
MIZRAHI, J
机构
[1] Department of Pharmacology, Laboratori Guidotti SpA2 2 Company related to A. Menarini-Industrie Farmaceutiche Riunite, Firenze, 56122 Pisa, Italy.
关键词
ANGIOTENSIN-II RECEPTOR SUBTYPES; DITHIOTHREITOL; AT1; AT2; HETEROGENEITY;
D O I
10.1016/0196-9781(93)90083-S
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin II (AII) receptor subtypes were investigated in bovine cerebellar cortical membranes (BCCM) using agonists and antagonists. Differences were observed whether the tissue for the characterization was used fresh or frozen. In fresh BCCM, AII and angiotensin III (AIII) (not selective), p-aminophenylalanine6-AII ([pNH2Phe6]AII) (AT2 selective), and DuP 753 (AT1 selective) interacted with two sites, at high and low affinity. In the presence of 10 mM dithiothreitol (DTT), the low-affinity site for AIII and [pNH2Phe6]AII and the high-affinity site for DuP 753 were no longer detectable. The same effect was obtained with 1 muM DuP 753, with only the low-affinity component of [pNH2Phe6]AII being resistant to this blocker. In frozen BCCM, DuP 753, PD 123319 (AT2 selective), and sarcosine1, isoleucine8-AII ([Sar1Ile8] All) yielded monophasic curves. These data confirm the presence of multiple receptors (AT1 and AT2) for AII on BCCM and suggest the possibility that within the AT2 receptors, one subtype, DTT sensitive, may exist. Alternatively, a heterogeneity in the AT1 class, with respect to the sensitivity to DuP753, may be considered.
引用
收藏
页码:1037 / 1041
页数:5
相关论文
共 50 条
  • [31] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .9. ANTIHYPERTENSIVE ACTIVITY IN RATS OF DUP-753, AN ORALLY ACTIVE ANTIHYPERTENSIVE AGENT
    WONG, PC
    PRICE, WA
    CHIU, AT
    DUNCIA, JV
    CARINI, DJ
    WEXLER, RR
    JOHNSON, AL
    TIMMERMANS, PBMWM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 252 (02): : 726 - 732
  • [32] LOSARTAN (DUP 753), AN ORALLY ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    WONG, PC
    BARNES, TB
    CHIU, AT
    CHRIST, DD
    DUNCIA, JV
    HERBLIN, WF
    TIMMERMANS, PBMWM
    CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (04): : 317 - 339
  • [33] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .7. CELLULAR AND BIOCHEMICAL PHARMACOLOGY OF DUP-753, AN ORALLY ACTIVE ANTIHYPERTENSIVE AGENT
    CHIU, AT
    MCCALL, DE
    PRICE, WA
    WONG, PC
    CARINI, DJ
    DUNCIA, JV
    WEXLER, RR
    YOO, SE
    JOHNSON, AL
    TIMMERMANS, PBMWM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 252 (02): : 711 - 718
  • [34] ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE BOVINE CEREBELLUM
    SPETH, RC
    FASEB JOURNAL, 1991, 5 (04): : A870 - A870
  • [35] PREJUNCTIONAL INHIBITION OF RENAL SYMPATHETIC-NERVE FUNCTION IN ANESTHETIZED DOGS BY DUP-753, A NONPEPTIDE ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST
    WONG, PC
    HART, SD
    TIMMERMANS, PB
    HYPERTENSION, 1990, 16 (03) : 337 - 337
  • [36] ORAL-ADMINISTRATION OF DUP-753, A SPECIFIC ANGIOTENSIN-II RECEPTOR ANTAGONIST, TO NORMAL-MALE VOLUNTEERS - INHIBITION OF PRESSOR-RESPONSE TO EXOGENOUS ANGIOTENSIN-I AND ANGIOTENSIN-II
    CHRISTEN, Y
    WAEBER, B
    NUSSBERGER, J
    PORCHET, M
    BORLAND, RM
    LEE, RJ
    MAGGON, K
    SHUM, L
    TIMMERMANS, PBMWM
    BRUNNER, HR
    CIRCULATION, 1991, 83 (04) : 1333 - 1342
  • [37] ANGIOTENSIN-II RECEPTOR ISOFORMS IN THE RAT ADRENAL-GLAND - STUDIES WITH THE SELECTIVE SUBTYPE ANTAGONISTS DUP-753 AND CGP42112A
    MONTIEL, M
    BARKER, S
    VINSON, GP
    JIMENEZ, E
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1993, 11 (01) : 69 - 75
  • [38] COMPARISON OF INHIBITORY POTENCY BY NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS PD123177 AND DUP-753 ON PROXIMAL NEPHRON AND RENAL TRANSPORT
    COGAN, MG
    LIU, FY
    WONG, PC
    TIMMERMANS, PBMWM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 259 (02): : 687 - 691
  • [39] NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .8. CHARACTERIZATION OF FUNCTIONAL ANTAGONISM DISPLAYED BY DUP-753, AN ORALLY ACTIVE ANTIHYPERTENSIVE AGENT
    WONG, PC
    PRICE, WA
    CHIU, AT
    DUNCIA, JV
    CARINI, DJ
    WEXLER, RR
    JOHNSON, AL
    TIMMERMANS, PBMWM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 252 (02): : 719 - 725
  • [40] INHIBITORY EFFECTS OF DUP-753 AND EXP3174 ON RESPONSES TO ANGIOTENSIN-II IN PULMONARY VASCULAR BED OF THE CAT
    MCMAHON, TJ
    KAYE, AD
    HOOD, JS
    MINKES, RK
    NOSSAMAN, BD
    KADOWITZ, PJ
    JOURNAL OF APPLIED PHYSIOLOGY, 1992, 73 (05) : 2054 - 2061